DiscoverHealth:Further9 - SCOTUS strikes down Affirmative Action | MDMA PTSD treatment Creative Financing | A Ray of light in VC fund formation | Ozempic Concerns
9 - SCOTUS strikes down Affirmative Action | MDMA PTSD treatment Creative Financing | A Ray of light in VC fund formation | Ozempic Concerns

9 - SCOTUS strikes down Affirmative Action | MDMA PTSD treatment Creative Financing | A Ray of light in VC fund formation | Ozempic Concerns

Update: 2023-06-301
Share

Description

SCOTUS has rejected use of race in higher education, which brings up a reflection on what we learned during the pandemic and the result of compounding generational discrimination. A new MDMA PTSD treatment is on the rise, while the health value of Ozempic use is being questioned. We’re covering these topics and more in Episode 9.

------🔎RESOURCES🔎

SCOTUS DECISION // https://bloom.bg/3r1UfrI

MAPS RAISING $85M FOR MDMA TREATMENT // https://on.wsj.com/3PBDOg4

MAPS B CORP SITE // https://mapsbcorp.com/

OZEMPIC: THIN BUT NOT NECESSARILY HEALTHY // https://on.wsj.com/3pv1xUA


------đź””SIGN UP FOR EPISODE NOTIFICATIONSđź”” https://www.podpage.com/healthfurther/


------📱FOLLOW HEALTH:FURTHER SOCIALS📱

INSTAGRAM // https://www.instagram.com/healthfurther/

TWITTER // https://twitter.com/HealthFurther

FACEBOOK // https://www.facebook.com/HealthFurther/

LINKEDIN // https://www.linkedin.com/company/health-further

TIKTOK // https://www.tiktok.com/@healthfurther

YOUTUBE // https://www.youtube.com/channel/UCFM4torjTIEkOLOD-p7FIKw
Comments 
In Channel
loading
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

9 - SCOTUS strikes down Affirmative Action | MDMA PTSD treatment Creative Financing | A Ray of light in VC fund formation | Ozempic Concerns

9 - SCOTUS strikes down Affirmative Action | MDMA PTSD treatment Creative Financing | A Ray of light in VC fund formation | Ozempic Concerns

Marcus Whitney